Clinical benefits of extended-release memantine (28 mg, once daily) as a function of disease severity in people with moderate to severe Alzheimer's disease: Post hoc analysis from a randomized trial

✍ Scribed by Tocco, Michael; Hendrix, Suzanne; Miller, Michael; Pejovic, Vojislav; Graham, Stephen

• Book ID: 123434623
• Publisher: Elsevier Science
• Year: 2013
• Tongue: English
• Weight: 51 KB
• Volume: 9
• Category: Article
• ISSN: 1552-5260
• DOI: 10.1016/j.jalz.2013.05.1345